The European Commission has granted marketing authorization for Gilead Sciences' twice-yearly injection for preventing HIV infection, the company said on Tuesday. The drug, known scientifically as ...

Gilead Sciences won European approval Tuesday for its new twice-annual HIV prevention shot, now called Yeytuo.

At the International AIDS Society meeting this year, a young woman from South Africa spoke. She is the first Black woman from ...

KENYA: KENYA has begun a yearlong study to examine why some patients on dolutegravir, the world’s leading HIV drug, are not ...

CVS Health , which runs the largest U.S. pharmacy benefit manager, will not add Gilead Sciences' new HIV prevention drug to ...

Sex workers and transgender people are among South Africa's most vulnerable populations after the Trump administration ...

Robert Suttle, an advocate for the rights of those living with HIV, was sentenced to jail after a former partner accused him ...

Honesty Bishop was attacked by her cellmate. Prison officials deemed her sexually active and kept her in isolation for more ...

In the mid-1990s, clinicians treating people with HIV began to notice a syndrome characterized by loss of limb fat, facial ...

After a year at the Maxwell Community Center in northwest Eugene, The Lavender Network will move to a new space at 1590 ...